جست‌وجوی استاد و پژوهشگر

• Plant Biology
• Environmental Stress Biology
• Crop Improvement
• +۳ مورد دیگر

Dr Farhad Masoomi-Aladizgeh is a Research Fellow in the School of Life and Environmental Sciences at the University of Sydney. His work focuses on understanding how environmental stresses like heat and drought impact crop fertility, particularly in cereal crops. He holds a BSc, MSc, and PhD in Plant Biology. His research emphasizes male reproductive systems in plants and seeks to identify molecular mechanisms underlying abiotic stress susceptibility to enhance climate resilience in crops. Education includes advanced training in plant sciences, with a focus on molecular biology and stress physiology. Current research projects explore transcriptome responses to stress, stress tolerance gene identification in crop relatives, and ABA-mediated stress protection in rice. His publications span plant proteomics, stress physiology, and molecular protocols, with a strong emphasis on drought and heat tolerance mechanisms. Notable work includes developing universal nucleic acid isolation protocols and analyzing stress responses in rice and cotton. No scientific awards are listed, but his contributions to crop resilience research are significant. He advises no current students but collaborates on interdisciplinary projects involving genomic and proteomic approaches to agricultural challenges. Research is centered at the University of Sydney with potential collaborations in plant science labs focused on environmental stress mitigation strategies.

Mehmet Koyutürkمشاهده پروفایل

استاد

• Systems Biology
• Computational Genomics
• Network Biology
• +۴ مورد دیگر

Mehmet Koyutürk serves as the Andrew R. Jennings Professor in the Department of Computer and Data Sciences at Case Western Reserve University's Case School of Engineering, with additional affiliation as a Member of the Cancer Genomics and Epigenomics Program at the Case Comprehensive Cancer Center. His computational research bridges algorithm development with biological applications, focusing on network-structured data analysis to address complex biomedical challenges. Dr. Koyutürk earned his Ph.D. in Computer Science from Purdue University following B.S. and M.S. degrees in Electrical Engineering and Computer Engineering from Bilkent University. His primary research domains include high-throughput biological data analysis, systems/network biology methodologies, data mining algorithms, and scientific computing optimization, with particular emphasis on phosphorylation networks, genomic interactions, and multi-omics integration. Recent publication trends reveal expanding applications of his network science expertise into Alzheimer's disease phosphoproteomics, bipolar disorder biomarker discovery, and intimate partner violence analysis, while maintaining core contributions to graph neural networks and biological link prediction. His group actively develops open-source analytical tools like RokaiXplorer for phospho-proteomic data accessibility. Scientific Recognition Andrew R. Jennings Professorship Dr. Koyutürk leads multiple NIH-funded initiatives including R01-LM012980 for phosphoproteomics analysis, U01-CA198941 (BD2K program) for big network integration, and R01-LM011247 for GWAS enhancement, complemented by NSF CAREER Award CCF-0953195. He serves on the steering committee for CWRU's Systems Biology and Bioinformatics graduate programs and as Associate Editor for IEEE/ACM Transactions on Computational Biology and Bioinformatics (TCBB), with extensive collaboration through Mark Chance's Center for Proteomics and Bioinformatics. His laboratory specializes in developing scalable algorithms for biological network analysis, currently advancing projects on kinase-substrate association prediction, co-phosphorylation network characterization in cancer, and network-based approaches to intimate partner violence data mining, with strong emphasis on translating computational methods into biomedical insights through open-source software dissemination.

• Drug safety science
• adaptive cellular stress responses
• cancer drug resistance
• +۷ مورد دیگر

Prof. Dr. Bob van de Water is a Professor of Drug Safety Science at Leiden University, where he serves as head of the Cancer Therapeutics and Drug Safety group within the Division of Drug Discovery & Safety at the Leiden Academic Centre for Drug Research (LACDR). His research focuses on understanding the molecular mechanisms underlying drug toxicity and cancer drug resistance. His primary research interests include: Adaptive cellular stress responses Cancer drug resistance and metastasis Cell signaling pathways Drug safety evaluation Functional genomics High throughput microscopy Molecular mechanisms of drug toxicity Toxicology Professor van de Water leads several significant research projects including studies on oncogenic protein tyrosine kinases in breast cancer, live cell imaging-based modeling of cellular toxicity pathways, and identification of novel druggable targets for different breast cancer types. He teaches in the Bio-Pharmaceutical Sciences programs at both BSc and MSc levels, offering courses on drug safety evaluation, signal transduction, and cellular toxicology. His research group includes current PhD candidates: Serkan Aslan Sibel Bahtiri Linda van den Berk Imke Bruns Gerhard Burger Professor van de Water has previously supervised numerous PhD students to completion, including: Olivier Béquignon Muriel Heldring Marije Niemeijer Lukas Wijaya Luc Bischoff

Junfang Wuمشاهده پروفایل

استاد

• Neurotrauma
• Neuropharmacology
• Neuroinflammation
• +۷ مورد دیگر

Dr. Junfang Wu is a Professor in the Department of Anesthesiology and holds a secondary appointment in Neurobiology at the University of Maryland School of Medicine. She serves as Associate Director of UM-MIND (University of Maryland - Medicine Institute for Neuroscience Discovery), Director of the Anesthesiology Center for Neuroscience Research, and Vice-Chair for Translational Research in the Department of Anesthesiology. Her academic journey includes a BM in Medicine, MS in Pharmacology from Jiangxi Medical College, and PhD in Neuropharmacology from Nanjing Medical University, followed by postdoctoral training at China's Institute of Materia Medica and NIH. Research Focus: Neurotrauma, neuroinflammation, autophagy-lysosomal pathway, extracellular vesicles, Hv1/NOX2/ROS, TrkB.T1 Key Techniques: Rodent models of SCI/TBI, behavioral evaluations, EV characterization, quantitative imaging, molecular/cellular biology Dr. Wu's research explores the cellular and molecular mechanisms of neurological dysfunction following CNS trauma, with emphasis on autophagy-lysosomal disruption, microglial Hv1 channels, and EV-mediated neuroinflammatory signaling. Her 2025 Aging and disease study reveals age-dependent transcriptional changes post-anesthesia, while 2024 Brain, Behavior, and Immunity work demonstrates how SCI alters EV cargoes to drive brain neuroinflammation. Her team recently discovered that Hv1 proton channel ablation in microglia provides neuroprotection in SCI models. Her scientific contributions are recognized through the 2025 Matjasko Professorship in Anesthesiology Research. She has secured multiple NIH grants including: R01 NS145443 (2025-2030): cGAS signaling in brain trauma-induced neuroinflammation R01 AG077541 (2022-2027): TBI olfactory dysfunction and dementia progression 2RF1 NS094527 (2016-2027): Autophagy mechanisms in SCI R01 NS110825 (2020-2026): Hv1 channel in SCI/TBI Dr. Wu's laboratory personnel include Research Associates Yun Li and Zhuofan Lei, Post-doctoral Fellows Balaji Krishnamachary and Zihui Wang, Research Assistant Hui Li, and medical student Ruth Park. Her work spans from bench research on lysosomal damage to clinical implications for Alzheimer's disease-related dementia (AD/ADRD) and potential therapeutic strategies.

Pixu Shiمشاهده پروفایل

استادیار

• Microbiome Research
• Longitudinal/Temporal Omic Data
• Integration of Omic Data
• +۲ مورد دیگر

Pixu Shi is an Assistant Professor in the Department of Biostatistics and Bioinformatics at Duke University's School of Medicine. Previously, they served as a Visiting Assistant Professor in the Department of Statistics at the University of Wisconsin-Madison (2018-2020) and as a Postdoctoral Researcher in the Department of Biostatistics at the University of Wisconsin-Madison (2016-2018). Dr. Shi earned their PhD in Biostatistics from the University of Pennsylvania in 2016 under advisor Hongzhe Li. They also hold an MS in Biostatistics from the University of Pennsylvania (2015), an MS in Statistics from Rutgers University (2012), and a BS in Statistics from Peking University (2010). Dr. Shi's research focuses on developing statistical methods for Microbiome Research, Longitudinal/Temporal Omic Data analysis, Integration of Omic Data, Spatial Omics, and High-dimensional Statistical Inference. Their work bridges statistical theory with practical applications in biomedical research, particularly in microbiome studies where they've made significant contributions with the TEMPTED (TEMPoral TEnsor Decomposition) method. The article trends show a strong focus on microbiome analysis, statistical methodology development, and applications in obesity, infectious disease, and cancer research. Their most recent work (2024-2025) demonstrates expertise in tensor decomposition methods, longitudinal data analysis, and integrating microbiome data with clinical outcomes across diverse areas including adolescent obesity, viral infections, and cancer metastases. Dr. Shi has secured multiple substantial research grants from major institutions including the National Institutes of Health (NIMH, NIAID, NCI, NIDDK, NIA), totaling over a decade of continuous funding for projects related to microbiome research, HIV/AIDS, cancer biomarkers, and metabolic studies. They actively contribute to education through teaching courses such as BIOSTAT 905: Linear Models and Inference at Duke University and previously taught statistics courses at the University of Wisconsin-Madison. Dr. Shi has also organized specialized workshop series including Quantitative Methods for HIV/AIDS, Microbiome, Immunology, and Cancer Bioinformatics.

Maria Fällmanمشاهده پروفایل

استاد

• Molecular microbiology
• Bacterial pathogenesis
• Infection biology
• +۷ مورد دیگر

Maria Fällman is a Professor at the Department of Molecular Biology at Umeå University, where she also serves as Deputy Head of Department. She is affiliated with Molecular Infection Medicine Sweden (MIMS), a leading research center for molecular infection medicine in Sweden. Dr. Fällman's research focuses on understanding the molecular mechanisms behind bacterial adaptation to different environments, with particular emphasis on Yersinia pseudotuberculosis and Salmonella enterica Typhimurium. Her group investigates gene regulation critical for establishing and maintaining infections, bacterial stress responses, and the molecular mechanisms of the Type Three Secretion System (T3SS). The lab has developed advanced methods for RNA extraction from complex tissue samples and performs in vivo gene expression analyses. Her publication record shows consistent contributions to understanding bacterial pathogenesis, with recent articles in high-impact journals including Nature Communications, Science, and PLOS Pathogens. Her work spans from fundamental molecular mechanisms of bacterial virulence to computational approaches for analyzing pathogen stress responses. A significant contribution is the PATHOgenex database (http://www.pathogenex.org), containing gene expression data of over 30 human pathogens exposed to different stress conditions. Dr. Fällman leads the Maria Fällman Lab, which has made important discoveries including the finding that sub-lethal doses of Yersinia result in persistent infection in mice with reprogramming of bacterial gene expression. Current projects focus on stress response modeling and deciphering heterogeneous populations of infecting bacteria using single-cell RNA-seq.

Juliet Coatesمشاهده پروفایل

دانشیار

• Plant Molecular Genetics
• Evolutionary Biology
• Cell Biology
• +۳ مورد دیگر

Dr Juliet Coates is an Associate Professor in Plant Molecular Genetics at the University of Birmingham, School of Biosciences, working part-time. Her research focuses on plant development, evolution, and cell biology, particularly the transition of plants to land. She advocates strongly for inclusion and diversity in academia, holding roles such as Quality Assurance and Enhancement (QAE) lead and APP lead. She earned her PhD from University College London and undergraduate degree from the University of Cambridge, specializing in Natural Sciences. Her teaching spans undergraduate and postgraduate levels, including courses on plant science, molecular genetics, and communication skills. Recent research projects include investigating submergence tolerance in seaweeds, MYB93 protein function in Arabidopsis and tomatoes, and DELLA proteins in moss. She has been awarded the University of Birmingham’s Excellent Practice Award and a Royal Society-Leverhulme Trust fellowship. Coates collaborates widely, including with artists and on public engagement projects like the 'Kelp Road' exhibition. Key roles: QAE Lead, APP Lead, Equality & Diversity Champion Research Themes: Plant evolution, environmental adaptation, and molecular genetics Grants: BBSRC, Gatsby Foundation, EU-Marie Skłodowska Curie Outreach: STEM ambassador, author of popular science, radio features

Qi Longمشاهده پروفایل

استاد

• Genomics
• Computational Biology
• Biostatistics
• +۱۰ مورد دیگر

Qi Long is a Professor at the University of Pennsylvania, holding joint appointments in the Department of Biostatistics, Epidemiology and Informatics (Perelman School of Medicine), Department of Computer and Information Science (School of Engineering and Applied Science), and Department of Statistics and Data Science (The Wharton School). He serves as Founding Director of the Center for Cancer Data Science, Associate Director of the Penn Institute for Biomedical Informatics, and Associate Director for Quantitative Data Science at the Abramson Cancer Center. His research bridges statistical and machine learning (ML/AI) method development with biomedical applications, focusing on precision medicine and population health. Education : Ph.D. (2005) and M.S. (2003) in Biostatistics from University of Michigan; B.S. (1998) in Computer Science from University of Science and Technology of China. Research interests include: Robust statistical and ML/AI methods for big health data (-omics, EHRs, imaging, mHealth) Multimodal data integration and subgroup heterogeneity analysis Missing data, causal inference, Bayesian methods, and clinical trials Data privacy, algorithmic fairness, and responsible AI in healthcare Foundation models and agentic AI for biomedicine His publications focus on privacy-preserving AI, fairness-aware ML, and integrative models for multi-omics and EHRs. Recent work explores LLMs and watermark detection in hybrid human-AI settings. Scientific Awards : Elected fellow: AAAS, ASA, IMS, ISI, AMIA He leads large NIH- and ARPA-H-funded initiatives, directing statistical coordinating centers for national clinical trials. His lab trains numerous PhD/Master’s students and postdocs, many of whom hold prestigious academic or industry positions.

• Genetics
• Genomics
• Molecular Biology
• +۳ مورد دیگر

Hajime Murakami is an Advanced Research Fellow at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition, where he conducts cutting-edge research on meiotic recombination mechanisms. His work focuses on understanding how cells manage the complex process of DNA double-strand break formation and repair during meiosis, with implications for human fertility and chromosome disorders. Dr. Murakami's research interests center on the molecular mechanisms of meiotic recombination, particularly the role of DNA double-strand breaks (DSBs) in chromosome segregation. His laboratory investigates how proteins like Hop1 and Red1 function as 'manager proteins' that direct the DNA 'scissors' to appropriate chromosomal locations, ensuring proper recombination while preventing errors that could lead to miscarriage or congenital syndromes. His work primarily uses yeast as a model system, which shares fundamental meiotic mechanisms with humans. Analysis of Dr. Murakami's publication record reveals a consistent focus on the molecular regulation of meiotic recombination across his career. His research has progressively uncovered sophisticated control mechanisms that ensure accurate chromosome segregation, with particular emphasis on how cells manage DNA break formation across chromosomes of different sizes. His work spans fundamental molecular mechanisms to potential clinical applications in reproductive medicine. Dr. Murakami has received significant recognition for his work, most notably a Medical Research Council (MRC) Career Development Award, which supports his ongoing research into the molecular basis of meiotic recombination. As an active researcher accepting PhD students in Biomedical Sciences, Dr. Murakami continues to advance our understanding of fundamental genetic processes that underlie human reproductive health. His laboratory at the Institute of Medical Sciences on Foresterhill Campus employs yeast genetics and molecular biology approaches to investigate the critical processes that ensure proper chromosome segregation during gamete formation.

• Synaptic Plasticity
• Long-Term Potentiation (LTP)
• Neuroscience
• +۳ مورد دیگر

Thomas J. O’Dell is a Professor of Physiology and Associate Director of the Brain Research Institute at the University of California, Los Angeles (UCLA). His research focuses on synaptic plasticity mechanisms, particularly long-term potentiation (LTP) and depression (LTD), in the hippocampus. He investigates β-adrenergic signaling, NMDA receptor dynamics, and astrocyte calcium signaling in learning and memory processes. O’Dell’s work bridges molecular neurobiology with behavioral neuroscience, emphasizing how synaptic changes underlie cognitive functions. Research Interests: Neuronal plasticity mechanisms in hippocampal circuits Role of NMDA receptors in synaptic function and disease β-Adrenergic modulation of LTP Calcium signaling in astrocytes and its impact on synaptic transmission Grants & Funding: NIH R21MH115404 (Mechanisms of homeostatic plasticity) NIH R01NS060677 (Astrocyte calcium signaling in striatum) NIH R01MH060919 (NMDA receptor signaling in LTP) Labs/Teams: O’Dell leads a lab at the UCLA Brain Research Institute, collaborating on projects involving synaptic physiology, proteomics, and behavioral neuroscience.

• Chronic Obstructive Pulmonary Disease (COPD)
• Respiratory Medicine
• Asthma
• +۴ مورد دیگر

Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.

Silvia Maioliمشاهده پروفایل

دانشیار

• Alzheimer's Disease
• Neuroscience
• Cholesterol Metabolism
• +۴ مورد دیگر

Silvia Maioli is an Associate Professor (Docent) and Principal Researcher at Karolinska Institutet's Department of Neurobiology, Care Sciences and Society, where she leads the 'Alzheimer's Disease Risk Factors & Sex-Specific Mechanisms' research group. She is also Facility Coordinator for the Animal Behavior Core Facility (ABCF) at Karolinska Institutet. Dr. Maioli earned her PhD in Pharmacology and Toxicology from the University of Bologna in 2011, followed by postdoctoral training at Karolinska Institutet. Her research focuses on understanding the biological mechanisms behind risk factors for neurodegenerative diseases like Alzheimer's Disease (AD), with particular emphasis on sex differences. Her laboratory investigates: Cholesterol metabolism in the brain and its role in AD progression The interplay between ApoE, cholesterol metabolites (oxysterols), and neurodegeneration Sex hormone interactions with brain cholesterol metabolism Multi-medication therapies and their sex-specific effects on AD pathology Identification of early biomarkers for women at risk of developing AD CYP46A1 as a potential therapeutic target for women at higher risk of AD Analysis of her recent publications reveals a strong translational approach combining mouse models with human clinical data to identify sex-specific therapeutic targets. Her work demonstrates that common multi-medication therapies affect AD pathology differently in male and female mice, and that protein activation in the brain may protect women against neurodegenerative diseases. Scientific Recognition Royal grant from King Gustaf V and Queen Victoria's Foundation for research on sex-differences in Alzheimer's Disease Nearly 20 million SEK from the Swedish Research Council Multiple grants from Alzheimerfonden, KID-funding, and other foundations Dr. Maioli actively mentors the next generation of researchers, currently serving as main supervisor for 2 PhD students and co-supervisor for 3 PhD students. She has directed two PhD theses and supervised 15 master's students. Her teaching includes directing the PhD Course 5239 'Behavioral Analysis in Rodents' and contributing to several other programs at Karolinska Institutet. As Facility Coordinator for the Animal Behavior Core Facility, Dr. Maioli leads a team specializing in behavioral testing of mouse models of neurodegenerative diseases. Her laboratory employs molecular biology techniques, in vitro and in vivo models, and analysis of human samples to investigate sex-specific mechanisms in Alzheimer's disease.

Olga Kovalchukمشاهده پروفایل

استاد

• Epigenetics
• Cancer Biology
• Radiation Biology
• +۵ مورد دیگر

Olga Kovalchuk is a Professor in the Department of Biological Sciences at the University of Lethbridge. She leads the Epigenetics of Health and Disease research laboratory, which is affiliated with the Southern Alberta Cancer Research Institute (SACRI) and Alberta Health Services/Alberta Cancer Foundation (AHS/ACF). Her research program has received significant funding including a $3.2 million Canada Foundation for Innovation (CFI) start-up grant and NSERC Discovery Grants. Dr. Kovalchuk's research focuses on the role of epigenetic mechanisms in health and disease, particularly in the context of radiation exposure and cancer. Her primary areas of investigation include epigenetic dysregulation in carcinogenesis, radiation epigenetics, DNA damage and repair mechanisms, and transgenerational effects of radiation exposure. She has made significant contributions to understanding how radiation-induced epigenetic changes affect genome stability, cancer development, and treatment responses. Analysis of her recent publications reveals a strong focus on microRNA regulation in cancer, sex-specific radiation responses, and the epigenetic basis of radiation-induced bystander effects. Her work demonstrates how epigenetic changes, particularly DNA methylation and microRNA expression patterns, mediate radiation responses in various tissues and can be transmitted across generations. Much of her research utilizes mouse models to investigate these mechanisms in vivo. Board of Governors Research Chair at University of Lethbridge CIHR Institute of Gender and Health Research Chair in New Perspectives in Gender, Sex and Health Canada Foundation for Innovation Start-up Funding ($3.2 Million) NSERC Discovery Grant recipient Editor's Choice Paper Award for research on radiation-induced bystander effects Cover Page feature for transgenerational radiation effects research Dr. Kovalchuk actively mentors numerous graduate students and postdoctoral fellows, with a research team comprising PhD students, MSc students, research assistants, and postdoctoral associates. Her laboratory collaborates extensively with researchers at MIT, Harvard University, and other institutions. She has secured significant grant funding including NSERC Discovery Grants and CFI start-up funds to support her research program investigating epigenetic mechanisms in radiation biology and cancer. Her laboratory, the Epigenetics of Health and Disease research group, maintains strong collaborations with the Southern Alberta Cancer Research Institute and has established partnerships with researchers across North America. Dr. Kovalchuk's work has important implications for understanding radiation risks, improving cancer therapies, and developing strategies to mitigate radiation damage.

Mikhail Gelfandمشاهده پروفایل

استاد

• molecular evolution
• comparative genomics
• systems biology
• +۷ مورد دیگر

Mikhail Gelfand is a Full Professor and Director of the Center for Molecular and Cellular Biology at Skolkovo Institute of Science and Technology (Skoltech), where he also serves as Vice President for Biomedical Research. His distinguished career spans multiple prestigious institutions including Lomonosov Moscow State University and the Higher School of Economics. His educational background includes: 1985: MSc in mathematics (functional analysis) 1993: PhD in physics-mathematics (biophysics) 1998: DSc in biology (molecular biology) 2007: full professor (bioinformatics) Professor Gelfand's research focuses on molecular evolution, comparative genomics, systems biology, and metagenomics. His work examines eukaryotic processes including alternative splicing, mRNA editing, and chromatin structure, as well as bacterial genome evolution and transcription regulation. His lab combines data on three-dimensional chromatin structure, epigenetic states, and gene expression to obtain an integrated view of genome functioning across diverse organisms from humans to amoebae. One major research direction focuses on the evolution of transcript splicing and editing, while comparative analysis of bacterial genomes yields functional annotations of novel enzymes, transporters, and transcription factors. His recent publications demonstrate a strong focus on RNA editing in cephalopods, bacterial genome analysis, and computational approaches to understanding chromatin structure. The work spans molecular biology, evolutionary biology, and bioinformatics, with particular emphasis on how RNA editing contributes to adaptation and molecular evolution across metazoans. His research shows how edited adenines are more frequently substituted with guanine in evolution than their unedited counterparts, suggesting RNA editing may enhance adaptation. His notable awards include: The President of Russian Federation's Award for Young Doctors of Science (2000) The "Best Scientist of the Russian Academy of Sciences" award (2004) A. A. Baev Prize in Genomics and Genoinformatics (2007) Member of Academia Europaea (2010) As Director of the Center for Molecular and Cellular Biology, Professor Gelfand leads a research group that combines computational and experimental approaches to study genome function and evolution. His lab's work has significant implications for understanding molecular mechanisms of evolution and adaptation across diverse biological systems, from bacteria to complex eukaryotes. His research on metagenomics extends to practical applications in areas including coral disease, aphids, and oil wells.

• Gastrointestinal Pathology
• Inflammatory Bowel Disease
• Colorectal Carcinoma
• +۷ مورد دیگر

Lindsay Alpert is an Associate Professor in the Department of Pathology at the University of Chicago's Pritzker School of Medicine. As a surgical pathologist specializing in gastrointestinal pathology, Dr. Alpert provides expert diagnostic services for neoplastic and non-neoplastic diseases of the gastrointestinal tract, biliary tree, and pancreas. Dr. Alpert received her MD from Columbia University College of Physicians and Surgeons in 2012. She completed her residency in Anatomic Pathology and fellowship in Gastrointestinal and Hepatic Pathology at the University of Chicago, finishing her fellowship in 2016 and residency in 2017. Dr. Alpert's research focuses on gastrointestinal pathology with particular expertise in inflammatory bowel disease, colorectal carcinoma, and the gut microbiome. Her work examines dysplasia patterns in IBD patients, histologic features of enteropathies, and the impact of therapeutic interventions on gastrointestinal tissues. She has made significant contributions to understanding the histologic spectrum of various gastrointestinal conditions and their clinical implications, with numerous publications in high-impact journals like Modern Pathology and Gastroenterology. Analysis of Dr. Alpert's recent publications reveals a strong focus on gastrointestinal pathology, particularly inflammatory bowel disease and colorectal neoplasia. Her work spans diagnostic pathology, molecular characterization of gastrointestinal tumors, and the impact of therapeutic interventions. Many studies examine dysplasia patterns in IBD patients across different age groups and presentations, while others investigate rare gastrointestinal conditions and their histologic features. Her research often bridges basic science with clinical applications, examining how dietary and pharmacological factors influence gastrointestinal pathology. Dr. Alpert actively collaborates with numerous researchers and clinicians at the University of Chicago and beyond, contributing to multidisciplinary studies that bridge pathology with clinical gastroenterology and oncology. Her network includes prominent colleagues such as John Hart, Namrata Setia, and Shu-Yuan Xiao. Dr. Alpert maintains an active research laboratory focused on gastrointestinal pathology, where she mentors trainees and collaborates with colleagues on various research projects examining the histopathology of gastrointestinal diseases. Her team works closely with clinicians to translate pathological findings into improved diagnostic criteria and patient care, particularly for complex cases involving inflammatory bowel disease and gastrointestinal neoplasia.